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Abstract
Background: Filamentous hemagglutinin (FHA) is a cell-associated and secreted adhesin produced by Bordetella pertussis
with pro-apoptotic and pro-inflammatory activity in host cells. Given the importance of the NF-kB transcription factor family
in these host cell responses, we examined the effect of FHA on NF-kB activation in macrophages and bronchial epithelial
cells, both of which are relevant cell types during natural infection.
Methodology/Principal Findings: Exposure to FHA of primary human monocytes and transformed U-937 macrophages, but
not BEAS-2B epithelial cells, resulted in early activation of the NF-kB pathway, as manifested by the degradation of cytosolic
IkBa, by NF-kB DNA binding, and by the subsequent secretion of NF-kB-regulated inflammatory cytokines. However,
exposure of macrophages and human monocytes to FHA for two hours or more resulted in the accumulation of cytosolic
IkBa, and the failure of TNF-a to activate NF-kB. Proteasome activity was attenuated following exposure of cells to FHA for
2 hours, as was the nuclear translocation of RelA in BEAS-2B cells.
Conclusions: These results reveal a complex temporal dynamic, and suggest that despite short term effects to the contrary,
longer exposures of host cells to this secreted adhesin may block NF-kB activation, and perhaps lead to a compromised
immune response to this bacterial pathogen.
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Introduction
Despite widespread vaccination against Bordetella pertussis (B.
pertussis), whooping cough is reemerging in most parts of the world.
B. pertussis colonizes the mucosa of the respiratory tract, where it
interacts with ciliated bronchial epithelial cells and local immune
cells, causing a highly contagious and prolonged respiratory disease
[1]. Filamentous hemagglutinin (FHA) is a 220 kDa protein
associated with the bacterial surface, but also secreted in substantial
amounts [2]. Studies using FHA-deficient B. pertussis strains implicate
this protein in tracheal colonization, cell adherence [3] and invasion
[4] of macrophages and epithelial cells by B. pertussis. Galactose-
dependent lectins and integrin receptors such as aMb2 and avb3 have
been suggested as eukaryotic binding sites for FHA [5,6].
In vitro and in vivo studies indicate that soluble FHA triggers
several immunomodulatory responses, as manifested by the
secretion of both inflammatory and anti-inflammatory cytokines
by macrophages [7,8], as well as by the induction of FHA-specific
T regulatory cells in a respiratory model [9].
NF-kB transcription factors mediate a large number of innate
immunomodulatory responses [10]. A number of pathogens have
evolved to manipulate this system in order to enhance their
survival in the host [11]. With the goal of identifying the
mechanisms by which FHA contributes to persistent and
prolonged B. pertussis infections, we analyzed the interaction of
FHA with components of the NF-kB pathway.
The NF-kB transcription factor pathway is activated by a
variety of microbial components that signal through innate
immune toll-like-receptors (TLR) and initiate the transcription of
genes associated with a spectrum of inflammatory responses [12].
NF-kB is a family of transcription-factor proteins; RelA/p50 is the
most well-studied member. This heterodimer is sequestered in the
cytoplasm of resting cells by the inhibitory protein IkBa.
Activation of the classical NF-kB pathway follows from IKKb
kinase-dependent serine phosphorylation of IkBa followed by
IkBa ubiquitination. This modification marks IkBa and subjects it
to rapid proteasomal degradation, resulting in the release of RelA/
p50 heterodimers and their translocation to the nucleus. RelA/
p50 then binds to kB DNA sites and initiates gene transcription
[13]. Inhibition of the NF-kB pathway has been linked to
attenuated inflammatory activity and apoptosis [14].
In the current study, we examined the ability of B. pertussis FHA
to affect activation of the NF-kB pathway as a possible strategy by
this pathogen to attenuate the immune response and prolong its
survival in the host.
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Materials and Methods
Eukaryotic cell lines and primary cell culture
The human monocyte-like cell line, U-937, and the human
bronchial epithelial cell line, BEAS-2B, were obtained from the
American Type Culture Collection (ATCC) (Rockville, MD)
(#CRL-15932 and #CRL-9606, respectively) and maintained in
culture using recommended conditions. U-937 cells were induced
to differentiate into macrophage-like cells by treatment with
10 ng/ml of phorbol 12-myristate 13-acetate (PMA) (Sigma, St.
Louis, MO), as previously described [8]. A-431 (epidermoid
carcinoma cell) extracts were used as a positive control in IkBa
immunoblots (Santa Cruz Biotechnology, Santa Cruz, CA). Fresh
human peripheral blood monocytes were obtained from healthy
donors. The use of these subjects was approved by the Stanford
University Administrative Panel on Human Subjects in Medical
Research. PBMCs (peripheral blood mononuclear cells) were
isolated from a Ficoll gradient. Monocytes were further purified
with the Miltenyi Biotec MACS magnetic beads separation
technology (Auburn, CA). Monocytes were placed in tissue culture
plates one day prior to the experiment. Non-adherent cells were
removed just prior to the experiment.
Reagents and antibodies
Purified B. pertussis FHA was kindly provided by Rino Rappuoli
and Mariagrazia Pizza (Novartis Vaccines, Siena, Italy) at a
concentration of 1 mg/ml. At Novartis Vaccines, FHA was
purified from culture supernatant of Bordetella pertussis Tohama I
using anion exchange chromatography (Matrex Cellufine Sulfate,
Millipore Corp., Watford, United Kindom), and filtration with
Millipack 100 filters. Enzyme linked immunosorbent assay
(ELISA) did not reveal the presence of pertactin, adenylate cyclase
toxin, or pertussis toxin in these FHA preparations. We estimated
endotoxin content using the Limulus amoebocyte lysate assay
(QCL-1000kit; BioWhittaker, Walkersville, MD), and found that
the FHA preparation used in these experiments contained 2 EU of
endotoxin units per microgram FHA protein, or 10 EU per ml
under assay conditions. We used B. pertussis LPS (List Biological,
Campbell, CA) as a control for this assay. In a previous publication
[8], we showed that FHA induces far more TNF-a secretion by U-
937 cells than would be expected from the known amounts of LPS
that contaminate these FHA preparations, based on a comparison
of the endotoxin activity in FHA and LPS preparations needed to
induce secretion of equivalent levels of TNF-a.
Human TNF-a was purchased from R&D Systems (Minnea-
polis, MN). Anti-RelA (C-20) and anti-C-terminal IkBa (C-21)
antibodies were purchased from Santa Cruz Biotechnology. Alexa-
fluor 568 goat anti-rabbit antibody was purchased from Molecular
Probes (Eugene, OR), and anti-actin AC-40 antibody was
purchased from Sigma.
ELISA
IL-8, IL-10 and TNF-a were measured in cell tissue culture
supernatants with solid phase sandwich ELISA kits (BioSource
International, Camarillo, CA) with the following lower limits of
detection: 0.39, 7.8, and 1 pg/ml, respectively.
Western blot analysis
Whole-cell lysates were prepared and immunoblots performed
as previously described [8].
Electrophoretic mobility shift assay (EMSA)
To prepare nuclear and cytosolic extracts, 107 cells were
harvested and washed with ice-cold PBS, centrifuged at 2506g
and re-suspended in 150 ml of cold buffer A (10 mM Tris–HCl
7.4, 10 mM NaCl, 3 mM MgCl2, 100 mg/ml PMSF, 0.5 mM
DTT and 1 mM Na3O4V). Cells were allowed to swell on ice for
30 minutes, and then 10 ml of 10% NP-40 was added. Cells were
mixed vigorously for 20 seconds and centrifuged for 10 seconds at
16,0006g. The supernatant, containing the cytoplasmic fraction,
was centrifuged again for 10 minutes at 16,0006g. The protein
content of the supernatant was determined with the BCA protein
assay (Pierce, Rockford, IL). The supernatant was mixed with 6x
loading buffer (denatured) and stored at 220uC for immunoblot
analysis. The nuclei were rinsed with buffer A, and centrifuged for
10 seconds at 16,0006g. The pellet was re-suspended in 60 ml
buffer C (20 mm HEPES pH 7.9, 420 mM NaCl, 1.5 mM
MgCl2, 0.2 mM EDTA, 25% glycerol, 100 mg/ml PMSF,
0.5 mM DTT, 100 mM Na3O4V, 3 mg/ml aprotinin, and 1 mg/
ml leupeptine (Roche, Indianapolis, IN) for 40 minutes on ice.
After five minutes centrifugation at 16,0006g, the supernatant
containing the nuclear fraction was collected, aliquoted and stored
at 280uC until its analysis by EMSA.
EMSA analysis
Oligonucleotide probes containing NF-kB enhancer sequences, as
well as the rest of the assay components (‘‘Gel shift assay core
system’’), were purchased from Promega (Madison, WI) and used
according to the manufacturer’s instructions. Briefly, DNA protein-
binding reactions were performed for 10 minutes at room
temperature with 15 mg nuclear extract, 1 ml P32 labeled oligo,
and 4 ml of binding buffer containing poly dI/dC. Samples were then
separated by electrophoresis in a 4% non-denaturing acrylamide gel
containing 0.5X TRIS-borate EDTA. Gels were dried and analyzed
by phosphorimaging (Molecular Dynamics, Sunnyvale, CA).
Proteasome activity
Cells were lysed in 0.3 ml proteasome lysing buffer (50 mM
TRIS-HCl pH 8, 140 mM KCl, 10 mM glucose, 2 mM ATP,
5 mM MgCl2 and 1 mM EDTA), with the following protease
inhibitors added just before use: 5 mM dithiothreitol, 0.1 mM
phenymethylsulfonyl fluoride, 2.2 mg/1 ml aprotonin and 2 mg/ml
leupeptin. The pellet was sonicated for 30 seconds and incubated on
ice for 30 minutes. The cell lysate was centrifuged for 10 minutes at
14,000 rpm at 4uC. The supernatant (cytosolic extract) was stored at
280uC until the enzymatic assay was performed.
Cytosolic extract (5 ug of total protein) was incubated in a total
of 100 ml of assay buffer containing 1M HEPES, 0.5 mM EDTA,
0.035% SDS and 70 mM of the substrate Suc-LLVY-AMC for
15 minutes at room temperature. Accumulation of the fluoro-
phore AMC was measured in a 96-well plate fluorometer (Gemini
II, Molecular Device) at an excitation wavelength of 360 nm and
emission wavelength of 460 nm, every 15 minutes for 45 minutes.
Activity was estimated by subtracting the fluorescence obtained for
proteasome-independent activity (in the presence of 60 mM MG-
132 proteasome inhibitor) from the values obtained in its absence.
The values shown represent the ratio of the proteasome activity in
each sample to that of the basal activity of the untreated extracts.
Results
FHA induces rapid degradation of IkBa in macrophages
but not in epithelial cells
We analyzed the effect of FHA on the NF-kB transcription-
factor pathway by incubating U-937 monocyte-derived macro-
phages, fresh human monocytes or the human bronchial epithelial
cell line BEAS-2B with 5 mg/ml FHA for up to 16 hours (Fig. 1A,
1B 1C). NF-kB activation was assessed by measuring the cytosolic
NF-kB and B. pertussis FHA
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levels of IkBa inhibitory protein. Proteasomal degradation of IkBa
is a key step that precedes nuclear translocation of RelA/p50 in
activated cells. Both monocyte-derived cells (Figs. 1A, 1B) and
epithelial cells (Fig. 1C) express significant levels of IkBa under
resting conditions. IkBa cytosolic levels in monocyte-derived cells
treated for various periods of time (0–8 hours) with 5 mg/ml FHA
suggested rapid degradation of IkBa, observable within 30 min-
utes in U-937 macrophages (Fig. 1A) and in fresh monocytes
(Fig. 1B). The levels of IkBa returned to baseline within two hours
in both cell types, and no further degradation was observed.
However, in BEAS-2B bronchial epithelial cells, IkBa was not
degraded upon similar treatment with FHA (Fig. 1C). The
putative IkBa band was confirmed as such using lysates from A-
431 cells, which over-express this molecule. These data suggest
that FHA is capable of inducing a rapid activation of the NF-kB
transcription factor pathway in monocyte-derived cells, but does
not appear to do so in epithelial cells.
NF-kB–DNA binding activity in FHA-treated cells
To assess NF-kB pathway activation further, we measured NF-
kB–DNA binding in the nuclear fractions of FHA-treated cells. U-
937 cells treated with 5 mg/ml FHA for up to four hours revealed
increased binding of RelA/p50 to kB–DNA binding sites in a
time-dependent manner, with significant levels of increased
binding at two and four hours (Fig. 2A). The specificity of
binding, as well as the nature of the transcription factors were
confirmed by displacement analyses with unlabeled NF-kB oligo
and a supershift analysis with p50 antibody (Fig. S1). Consistent
with the results shown in Fig. 1, FHA did not induce NF-kB–DNA
binding in BEAS-2B cells. However, TNF-a, a classical activator
of NF-kB, induced DNA binding within 15 minutes, confirming
the ability of the BEAS-2B cells to activate this transcription factor
in response to signals other than FHA (Fig. 2B).
FHA induces both inflammatory and anti-inflammatory
cytokines in monocyte- derived cells but not in a
bronchial epithelial cell line
The NF-kB pathway is responsible for the transcriptional
activation of genes encoding a variety of inflammatory cytokines.
We found that macrophage-like transformed cells and primary
monocytes exposed to 5 mg/ml FHA for two hours secreted
significantly higher levels of TNF-a and IL-8 than did untreated
cells, as detected by ELISA. TNF-a and IL-8 levels from FHA-
treated U-937 macrophages were 14- and 12-fold higher than those
from untreated cells (Table 1). TNF-a and IL-8 levels from fresh
monocytes reached 4.2460.04 ng/ml and 7662.3 ng/ml, respec-
tively, while in untreated cells these cytokines remained below the
limits of detection (1.0 and 0.39 pg/ml, respectively). No TNF-a was
detected in the supernatant of FHA-treated BEAS -2B cells, but
1.3460.069 ng/ml of IL-8 was detected following treatment (12 fold
increase, Table 1), indicating perhaps a role for a transcription factor
other than NF-kB. Concomitant with the FHA induction of
inflammatory cytokines in monocyte-derived cells, the anti-inflam-
matory cytokine IL-10 was also produced: U-937 macrophages,
2.260.071 ng/ml, 170 fold increase, and primary monocytes,
0.4760.1 ng/ml. No IL-10 was detected in BEAS-2B cells treated
with FHA. These data support the hypothesis that FHA can induce
NF-kB activity, but suggest a complex set of downstream effects.
Prolonged exposure to FHA inhibits proteasomal activity
and prevents activation of the NF-kB pathway
Since immune and other host cells may be exposed to FHA over
extended periods of time during the course of infection, we were
interested in the cellular responses triggered by more prolonged
incubation with FHA. Activation of the NF-kB pathway by a
variety of signals results in cyclical fluctuation of IkBa levels in the
cytosol [15]. IkBa is constantly degraded in response to a positive
signal, but is quickly synthesized in the nucleus and transported
back to the cytosol such that the original levels are restored. This
pattern is repeated as long as the cells are exposed to a positive
signal. However, the activation of the NF-kB pathway by FHA
resulted in a different response. Treatment for 15 minutes with
10 ng/ml TNF-a induced complete degradation of IkBa in U-937
macrophages (Fig. 3A), as well as in fresh monocytes (data not
shown) and in BEAS-2B bronchial epithelial cells (Fig. 3B). This
degradation appeared to be proteasomally mediated, based on the
use of the proteasome inhibitor ALLN208719 (Fig. S2). Surpris-
ingly, two hours of pretreatment with 5 mg/ml FHA completely
prevented the degradation of IkBa induced by TNF-a in U-937
cells (Fig. 3A) and partially prevented the degradation in BEAS-2B
cells (Fig. 3B). These data suggest that prolonged exposure of cells
to FHA does not further activate the NF-kB pathway; moreover,
such exposure appears to prevent further activation by other
stimuli, such as TNF-a. Similar results demonstrating FHA
inhibition of IkBa degradation were obtained with Bp-LPS and
IL-1b (Figs. S2, S3).
Figure 1. IkBa cytosolic levels in FHA-treated U-937 monocyte-
derived macrophages, fresh human monocytes and BEAS-2B
bronchial epithelial cells. (A) U-937 derived macrophages, (B) fresh
human monocytes and (C) BEAS-2B cells were treated with 5 mg/ml FHA
for the indicated time periods. Cytoplasmic protein extracts were
analyzed by immunoblot procedures with an antibody directed against
the C-terminus of IkBa. A-431 cell lysate was used as a positive control
to identify IkBa. Equal amounts of loaded protein were confirmed by
anti-actin immunoblotting. This is a representative experiment of four
performed under similar conditions.
doi:10.1371/journal.pone.0003825.g001
NF-kB and B. pertussis FHA
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FHA inhibits the induced nuclear translocation of RelA in
BEAS-2B cells
Activation of the NF-kB pathway results in the dissociation of
NF-kB molecules from IkBa and their translocation to the
nucleus. We took advantage of the flat morphology of BEAS-2B
cells and their large cytoplasmic areas to analyze, by immunoflu-
orescent staining, the translocation of RelA from cytosol to
nucleus. Following treatment with FHA, TNF-a, or both, cells
were stained with a fluorescent antibody for RelA, as described in
Methods. Untreated and two-hour FHA-treated cells revealed that
RelA was localized primarily in the cytosol (Figs. 4A, 4B). Fifteen-
minute treatment with 10 ng/ml TNF-a induced translocation of
RelA to the nucleus, as shown by the uniform staining of both
cytosol and nucleus (Fig. 4C). FHA pretreatment reduced the
nuclear translocation of RelA induced by TNF-a (Fig. 4D). These
findings support the proposed partial inhibition of IkBa
proteasomal degradation by FHA, as previously discussed (Fig. 3A).
Proteasomal activity is blunted by FHA treatment
Other data suggested that FHA does not interfere with the
phosphorylation and ubiquitination of IkBa 2 functions that are
needed for proteasomal degradation (Fig. S4) – we further
examined whether prolonged treatment with FHA directly affects
proteasome activity. Whole-cell lysates were prepared from cells
treated with FHA for various periods of time (0–8 hours). The
lysates were then incubated with fluorogenic proteasome-specific
substrate, as described in Material and Methods. As illustrated in
U-937 macrophages, FHA induced a 30, 27 and 43% inhibition of
proteasomal activity at two, four and eight hours, respectively, in
comparison to untreated macrophages (Fig. 5A). In BEAS-2B cells,
FHA induced a 48, 44 and 25% inhibition at two, four and eight
hours, respectively, in comparison to untreated cells (Fig. 5B).
These results imply that longer exposures of both macrophages
and epithelial cells to FHA result in attenuated proteasome
function, which may contribute to reduced NF-kB pathway
activity.
Discussion
A well-described feature of mammalian innate responses to
microorganisms involves recognition of common molecular
patterns, such as lipopolysaccharide and peptidoglycan, and
subsequent activation of the NF-kB transcription factor pathway.
Figure 2. NF-kB–DNA binding activity in U-937 monocyte-derived macrophages and BEAS-2B bronchial epithelial cells treated with
FHA. Nuclear extracts from U-937 derived macrophages (A) and BEAS-2B cells (B) were treated as indicated and analyzed for DNA binding activity to
kB responsive elements by EMSA. The migration position of the NF-kB heterodimeric-binding complex is indicated, as determined previously in TNF-
a treated cells, using super-shift analysis with unlabeled NF-kB oligo and anti-p50 (Fig. S1). These are representative experiments of three sets
performed under similar conditions.
doi:10.1371/journal.pone.0003825.g002
Table 1. FHA-induced cytokine secretion in U-937 derived
macrophages, fresh human monocytes, and BEAS-2B cells.
TNF-a
(ng/ml)
IL-8
(ng/ml)
IL-10
(ng/ml)
U-937 cells media only 0.02560.015 2.760.3 0.01360.001
+ FHA 0.36060.02 3263.2 2.260.071
Fresh monocytes media only ND ND ND
+ FHA 4.2460.04 7662.3 0.4760.1
BEAS-2B cells media only ND 0.10860.008 ND
+ FHA ND 1.34160.069 ND
Cells were incubated for two hours with 5 mg/ml FHA, washed and further
incubated for 16 hours with media alone. TNF-a, IL-8, and IL-10 levels were
analyzed in cell supernatants by ELISA. These are representative values from
one of three experiments performed under similar conditions. Statistical
significance was analyzed by t test (two-sample test, assuming equal variances);
FHA induced significant responses in all cases where cytokines could be
detected (p , 0.000001).
ND= not detected.
doi:10.1371/journal.pone.0003825.t001
NF-kB and B. pertussis FHA
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It is not surprising that some pathogens, such as Y. pestis, Y.
enterocolitica and Salmonella enterica Typhimurium, have evolved
mechanisms for exploiting this regulatory system as a means for
securing a host niche [16–18]. Among the bordetellae, a type III-
secretion system in B. bronchiseptica is responsible for inhibition of
the NF-kB pathway in murine macrophages [19,20].
Virulence factors act in concert during natural infections of B.
pertussis. Under these circumstances, it is difficult or impossible to
dissect out the contributions of individual factors. FHA is well
characterized as an adhesin. However, the significant amounts of
FHA secreted by B. pertussis have led to speculation that this
soluble molecule has an additional role in pathogenesis. Although
the amounts or concentrations of secreted FHA in vivo are unclear,
we see great value in understanding the potential consequences of
FHA interactions with host cells. We focused on the NF-kB
response system because of its central role in inflammation and
because of previous observations of FHA-associated TNF-a
secretion and apoptosis by mononuclear leukocytes [8]. We
measured NF-kB activity in two cell types, both of which are
relevant to B. pertussis infection: mononuclear leukocytes, i.e., a
monocyte-derived macrophage cell-line (U-937) and fresh human
monocytes. We also analyzed the interactions of FHA with a cell-
line model of bronchial epithelial cells, which is a major target cell
type for B. pertussis.
Our results revealed a dynamic, time-dependent NF-kB
pathway response to FHA where, despite the initial rapid
activation of the pathway in macrophages, prolonged exposure to
FHA inhibited this pathway and suppressed subsequent responses
to other inflammatory signals. In contrast, in bronchial epithelial
cells, FHA blocked activation of the NF-kB pathway at all
examined time points. Cells were analyzed with various assays that
assess the activation state of the NF-kB pathway, including IkBa
degradation, nuclear translocation of the transcription factor,
DNA binding of the transcription factor, and the secretion of NF-
kB-regulated cytokines, such as TNF-a and IL-8. Up-regulated
IL-6 and TNF-a secretion were previously reported in the murine
macrophage cell line J774 following treatment with soluble FHA
[7]. The chemokine IL-8 was detected in the supernatant of
epithelial cells exposed to FHA; however, since NF-kB is not
activated by FHA in these cells, we speculate that a different
transcription factor is responsible for IL-8 transcription. NF-kB is
believed to be expressed in BEAS-2B epithelial cells, based on
previous microarray-derived data [21] and based on the NF-kB
pathway-associated responses of BEAS-2B cells to TNF-a
observed in this study.
FHA is purified from liquid cultures of B. pertussis. LPS levels
were previously measured in the FHA samples and found to be
very low but not absent [8]. However, we previously showed that
B. pertussis LPS is a weak inducer of inflammatory responses, as
well as apoptosis, in the same cell types, when compared to FHA
[8]. To verify if the initial inflammatory response might be due in
part to the minute amounts of contaminating LPS, we pretreated
FHA with 10 mg/ml polymixin B and then used this preparation to
treat differentiated U-937 cells. We found that IkBa was degraded
by 0.5 hour following exposure to either polymixin B-pretreated
FHA or untreated FHA, suggesting that LPS does not contribute
significantly to the rapid activation of NF-kB by FHA (Fig. S5).
It was previously suggested that FHA binds to macrophages
through aMb2 integrin receptors [5]. These receptors are capable
Figure 3. IkBa cytosolic levels in U-937 monocyte-derived
macrophages and BEAS-2B bronchial epithelial cells treated
with FHA, TNF-a, or both. U-937 derived macrophages (A) and BEAS-
2B cells (B) were treated for the indicated time periods with 10 ng/ml
TNF-a or 5 mg/ml FHA, or both. Cytoplasmic protein extracts were
analyzed by immunoblot procedures with an antibody directed against
the C-terminus of IkBa. A-431 cell lysate was used as a positive control
to identify IkBa. Equal amounts of loaded protein were confirmed by
anti-actin immunoblotting. This is a representative experiment of four
performed under similar conditions.
doi:10.1371/journal.pone.0003825.g003
Figure 4. Nuclear translocation of the RelA NF-kB subunit in
BEAS-2B epithelial cells. BEAS-2B cells were incubated with either
media alone (A), 5 mg/ml FHA for two hours (B), 10 ng/ml TNF-a for
15 minutes (C), or 5 mg/ml FHA for two hours and then 10 ng/ml TNF-a
for 15 minutes (D). Cells were fixed, permeabilized and labeled with an
antibody specific for the NF-kB RelA subunit, followed by an Alexa 568-
labeled secondary antibody, and observed by confocal microscopy, as
described in Materials and Methods. This is a representative experiment
of three performed under similar conditions.
doi:10.1371/journal.pone.0003825.g004
NF-kB and B. pertussis FHA
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of activating NF-kB [22]. However, it remains to be determined
whether this is the mechanism by which FHA activates NF-kB. It
is possible that the different responses of macrophages and
epithelial cells originate in the distinct repertoire of receptors
expressed by these cells. A prior study showed that in BEAS-2B
cells exposed to FHA-coated wells, the NF-kB pathway is activated
in an RGD motif-dependent manner [23]. We speculate that
differences in the presentation of FHA (surface-associated versus
soluble) may account for the discrepancy in the responses
identified in BEAS-2B epithelial cells. Since cells are exposed in
vivo to both surface-associated FHA and soluble FHA, both models
of FHA presentation are relevant.
As reported by others, we observed high levels of secretion of
the anti-inflammatory cytokine IL-10 by U-937 macrophages and
fresh human monocytes exposed to FHA. Additional immuno-
suppressive activities have been attributed to FHA, and associated
with the induction of T regulatory cells. IL-10 was shown to
disrupt NF-kB activation by interfering with IkBa degradation
[24] and IKKb2induced phosphorylation [25]. Further analyses
are needed to determine whether IL-10 alone mediates FHA
inhibitory effects in macrophages. However, IL-10 is not secreted
by epithelial cells and thus cannot explain the inhibitory effects in
BEAS-2B cells.
The inhibition of proteasomal activity in cells treated for
prolonged periods of time with FHA in this study may explain the
limited degradation of IkBa in these cells and may offer support
for our previous published observations, where similar conditions
induced cell apoptosis [8]. The accumulation of IkBa has been
shown in other systems to lead to apoptosis [26]. Other pathogens
produce factors that are proteasome inhibitors. In fact, one of the
most popular proteasome inhibitors used in laboratory experi-
ments is lactacystin, which is produced by Streptomyces [27].
Interestingly, proteasome inhibition was previously shown to
increase IL-10 secretion by the promonocytic cell line THP-1 in
response to LPS [28]. The ability of FHA to interfere with such a
critical function as proteasome activity may explain its role in the
attenuation of the immune response to Bordetella infection. Our
data suggest a previously unrecognized mechanism of action for
the soluble-secreted form of FHA. Given that FHA is a component
of acellular pertussis vaccines, further examination of these
activities may be prudent.
Supporting Information
Figure S1 Specificity and super-shift analysis of NF-kB DNA
binding activity in U-937 macrophages. Nuclear extracts from U-
937 derived macrophages treated with media for 8 hours, 5 mg/ml
FHA for 8 hours, or TNF-a for 15 min were incubated for one
hour with or without unlabeled NF-kB oligo or with anti-p50
antibody as described and analyzed for DNA binding by EMSA.
Incubation with anti-p50 antibody resulted in a shift or delay of
the p50 subunit migration, as indicated in the figure, confirming its
contribution to the RelA/p50 transcription factor band. This is
representative of three assays performed under similar conditions.
Found at: doi:10.1371/journal.pone.0003825.s001 (0.04 MB TIF)
Figure S2 TNF-a and LPS reveal proteosome-dependent NF-
kB activation that is attenuated by FHA. Fresh human monocytes
were pre-treated as indicated with media or 10 mM ALLN208719
or 5 mg/ml FHA and then activated for 15 minutes with 10 ng/ml
TNF-a or 60 minutes with 10 mg/ml Bordetella pertussis LPS.
Cytoplasmic extracts were analyzed by immunoblot procedures
with an antibody directed against the C-terminus of IkBa. This is
a representative experiment of three performed under similar
conditions.
Found at: doi:10.1371/journal.pone.0003825.s002 (0.07 MB TIF)
Figure S3 FHA attenuates NFkB activity triggered by TNF-a,
LPS or IL-1b in human monocytes and BEAS-2B cells. Fresh
human monocytes (A) or BEAS-2B cells (B) were pre-treated as
indicated, with media or 5 mg/ml FHA and then exposed for
15 minutes to 10 ng/ml TNF-a or 60 minutes with 10 mg/ml
Bordetella pertussis LPS or 60 minutes with 50 ng/ml IL-1b, as
indicated. Cytoplasmic extract protein was analyzed with
immunoblot procedures using an antibody directed against the
C-terminus of IkBa. This is a representative experiment of three
performed under similar conditions.
Found at: doi:10.1371/journal.pone.0003825.s003 (0.08 MB TIF)
Figure S4 Phosphorylation and ubiquitination of IkBa in
BEAS-2B and U-937 cells induced by FHA. A: BEAS-2B cells
and B: differentiated U-937 cells, as described in methods, were
pretreated with 10 mM ALLN208719 and then with media alone,
or 5 mg/ml FHA, or 10 ng/ml TNF-a, or 5 mg/ml FHA and then
10 ng/ml TNF-a, for the times indicated. Equal amounts of whole
Figure 5. Proteasome activity in U-937 monocyte-derived
macrophages and BEAS-2B bronchial epithelial cells. Protea-
some activity was determined in lysates of U-937 monocyte-derived
macrophages (A) and BEAS-2B bronchial epithelial cells (B) by
incubating the lysates with the proteasome substrate Suc-LLVY-AMC,
and then measuring the accumulation of free AMC fluorophore, which
is cleaved from the substrate LLVY-AMC by the proteasome. These
results are the mean ratios from six separate experiments, as described
in Methods. Measurements were performed in quadruplicate and
statistical significance was determined by the paired Student t-test. The
reductions in proteasome activity were statistically significant (*) at 2 hr,
4 hr, and 8 hr (p,0.001) for both cell types.
doi:10.1371/journal.pone.0003825.g005
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cell lysate were immunoprecipitated with anti-IkBa antibody and
immunoblotted with anti-ubiquitinin or p-ser-IkBa as indicated.
This is a representative assay out of three assays performed under
similar conditions.
Found at: doi:10.1371/journal.pone.0003825.s004 (0.08 MB TIF)
Figure S5 IkBa cytosolic levels in FHA-treated U-937 cells:
Pretreatment with polymixin B, MG-132 or calpain inhibitors. U-
937 cells were pretreated for 60 minutes with 10 mM MG-132 or
10 mM calpain and then incubated with 5 mg/ml FHA for the
times indicated. Additionally, cells were treated for the times
indicated with 5 mg/ml FHA which had been pretreated for
60 min with 10 mg/ml polymixin B. Cytoplasmic extract protein
was analyzed with immunoblot procedures using an antibody
directed against the C-terminus of IkBa. This is a representative
experiment of three performed under similar conditions.
Found at: doi:10.1371/journal.pone.0003825.s005 (0.91 MB TIF)
Acknowledgments
The authors thank Drs. Rino Rappuoli and Mariagrazia Pizza (Novartis
Vaccines, Siena, Italy) for their generous gift of purified FHA.
Author Contributions
Conceived and designed the experiments: TA HK DAR. Performed the
experiments: TA HK. Analyzed the data: TA HK DAR. Contributed
reagents/materials/analysis tools: DAR. Wrote the paper: TA DAR.
References
1. Mattoo S, Cherry JD (2005) Molecular pathogenesis, epidemiology, and clinical
manifestations of respiratory infections due to Bordetella pertussis and other
Bordetella subspecies. Clin Microbiol Rev 18: 326–382.
2. Jacob-Dubuisson F, Kehoe B, Willery E, Reveneau N, Locht C, et al. (2000)
Molecular characterization of Bordetella bronchiseptica filamentous haemag-
glutinin and its secretion machinery. Microbiology 146 (Pt 5): 1211–1221.
3. Relman DA, Domenighini M, Tuomanen E, Rappuoli R, Falkow S (1989)
Filamentous hemagglutinin of Bordetella pertussis: nucleotide sequence and
crucial role in adherence. Proc Natl Acad Sci U S A 86: 2637–2641.
4. Ishibashi Y, Relman DA, Nishikawa A (2001) Invasion of human respiratory
epithelial cells by Bordetella pertussis: possible role for a filamentous
hemagglutinin Arg-Gly-Asp sequence and alpha5beta1 integrin. Microb Pathog
30: 279–288.
5. Relman D, Tuomanen E, Falkow S, Golenbock DT, Saukkonen K, et al. (1990)
Recognition of a bacterial adhesion by an integrin: macrophage CR3 (alpha M
beta 2, CD11b/CD18) binds filamentous hemagglutinin of Bordetella pertussis.
Cell 61: 1375–1382.
6. Ishibashi Y, Claus S, Relman DA (1994) Bordetella pertussis filamentous
hemagglutinin interacts with a leukocyte signal transduction complex and
stimulates bacterial adherence to monocyte CR3 (CD11b/CD18). J Exp Med
180: 1225–1233.
7. McGuirk P, Mills KH (2000) Direct anti-inflammatory effect of a bacterial
virulence factor: IL-10- dependent suppression of IL-12 production by
filamentous hemagglutinin from Bordetella pertussis. Eur J Immunol 30:
415–422.
8. Abramson T, Kedem H, Relman DA (2001) Proinflammatory and proapoptotic
activities associated with Bordetella pertussis filamentous hemagglutinin. Infect
Immun 69: 2650–2658.
9. McGuirk P, McCann C, Mills KH (2002) Pathogen-specific T Regulatory 1
Cells Induced in the Respiratory Tract by a Bacterial Molecule that Stimulates
Interleukin 10 Production by Dendritic Cells: A Novel Strategy for Evasion of
Protective T Helper Type 1 Responses by Bordetella pertussis. J Exp Med 195:
221–231.
10. Karin M, Lawrence T, Nizet V (2006) Innate immunity gone awry: linking
microbial infections to chronic inflammation and cancer. Cell 124: 823–835.
11. Neish AS (2004) Bacterial inhibition of eukaryotic pro-inflammatory pathways.
Immunol Res 29: 175–186.
12. Lin WW, Karin M (2007) A cytokine-mediated link between innate immunity,
inflammation, and cancer. J Clin Invest 117: 1175–1183.
13. Schulze-Luehrmann J, Ghosh S (2006) Antigen-receptor signaling to nuclear
factor kappa B. Immunity 25: 701–715.
14. Luo JL, Kamata H, Karin M (2005) IKK/NF-kappaB signaling: balancing life
and death–a new approach to cancer therapy. J Clin Invest 115: 2625–2632.
15. Hoffmann A, Levchenko A, Scott ML, Baltimore D (2002) The IkappaB-NF-
kappaB signaling module: temporal control and selective gene activation.
Science 298: 1241–1245.
16. Tato CM, Hunter CA (2002) Host-pathogen interactions: subversion and
utilization of the NF-kappa B pathway during infection. Infect Immun 70:
3311–3317.
17. Ye Z, Petrof EO, Boone D, Claud EC, Sun J (2007) Salmonella effector AvrA
regulation of colonic epithelial cell inflammation by deubiquitination.
Am J Pathol 171: 882–892.
18. Orth K (2002) Function of the Yersinia effector YopJ. Curr Opin Microbiol 5:
38–43.
19. Yuk MH, Harvill ET, Cotter PA, Miller JF (2000) Modulation of host immune
responses, induction of apoptosis and inhibition of NF-kappaB activation by the
Bordetella type III secretion system. Mol Microbiol 35: 991–1004.
20. Legarda D, Klein-Patel ME, Yim S, Yuk MH, Diamond G (2005) Suppression
of NF-kappaB-mediated beta-defensin gene expression in the mammalian
airway by the Bordetella type III secretion system. Cell Microbiol 7: 489–497.
21. Belcher CE, Drenkow J, Kehoe B, Gingeras TR, McNamara N, et al. (2000)
The transcriptional responses of respiratory epithelial cells to Bordetella pertussis
reveal host defensive and pathogen counter-defensive strategies. Proc Natl Acad
Sci U S A 97: 13847–13852.
22. Kettritz R, Choi M, Rolle S, Wellner M, Luft FC (2004) Integrins and cytokines
activate nuclear transcription factor-kappaB in human neutrophils. J Biol Chem
279: 2657–2665.
23. Ishibashi Y, Nishikawa A (2003) Role of nuclear factor-kappa B in the regulation
of intercellular adhesion molecule 1 after infection of human bronchial epithelial
cells by Bordetella pertussis. Microb Pathog 35: 169–177.
24. Ward PA, Lentsch AB (2002) Endogenous regulation of the acute inflammatory
response. Mol Cell Biochem 234–235: 225–228.
25. Schottelius AJ, Mayo MW, Sartor RB, Baldwin AS Jr (1999) Interleukin-10
signaling blocks inhibitor of kappaB kinase activity and nuclear factor kappaB
DNA binding. J Biol Chem 274: 31868–31874.
26. Jana NR, Dikshit P, Goswami A, Nukina N (2004) Inhibition of proteasomal
function by curcumin induces apoptosis through mitochondrial pathway. J Biol
Chem 279: 11680–11685.
27. Fenteany G, Schreiber SL (1998) Lactacystin, proteasome function, and cell fate.
J Biol Chem 273: 8545–8548.
28. Cuschieri J, Gourlay D, Garcia I, Jelacic S, Maier RV (2004) Implications of
proteasome inhibition: an enhanced macrophage phenotype. Cell Immunol 227:
140–147.
NF-kB and B. pertussis FHA
PLoS ONE | www.plosone.org 7 November 2008 | Volume 3 | Issue 11 | e3825
